EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

β-Elemene Inhibits K-RAS Mutant Non-Small Cell Lung Cancer Progression and Is Associated with Ferroptosis- and Autophagy-Related Changes

Yue Cao, Jun Zhu, Jianle Chen, Tingting Bian, Kunxin Wang, Jianguo Zhang, Yifei Liu, Yilu Gu Gu, Jiefei Miao

Acta Poloniae Pharmaceutica - Drug Research · 23.06.2026 · 84 (1) · 119-128

DOI: 10.32383/appdr/222556 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Poloniae Pharmaceutica - Drug Research, online erschienen am 23.06.2026. Verfasst von Yue Cao und 8 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer remains the leading cause of cancer-related death worldwide, and non-small cell lung cancer (NSCLC) accounts for the majority of cases. K-RAS mutations are common in NSCLC and are associated with poor prognosis, while effective therapeutic options remain limited. β-Elemene, a natural compound extracted from Curcuma aromatica, has shown antitumor activity, but its effects in K-RAS mutant NSCLC remain incompletely understood. In this study, we investigated the inhibitory effects of β-elemene on K-RAS mutant NSCLC cells and explored its association with ferroptosis- and autophagy-related changes. In A549 and H1650^G12C cells, β-elemene inhibited cell proliferation in a dose- and time-dependent manner, as confirmed by CCK-8 and colony formation assays. β-Elemene treatment was accompanied by changes in ferroptosis-related markers, including altered GPX4 and SLC7A11 expression, increased malondialdehyde (MDA) levels, and decreased glutathione (GSH) content, and these effects were partially reversed by Ferrostatin-1. Transmission electron microscopy revealed mitochondrial alterations consistent with oxidative damage. In addition, β-elemene treatment was associated with changes in autophagy-related proteins, including LC3, p62, and Beclin-1. Interference with the autophagy-related pathway by Wortmannin attenuated some of the β-elemene-associated ferroptosis-related changes. Taken together, our findings suggest that β-elemene suppresses K-RAS mutant NSCLC cell progression and is associated with ferroptosis-related and autophagy-related alterations. Further studies are needed to clarify the causal relationship between these processes.

Zitieren

APA

Cao, Y., Zhu, J., Chen, J., Bian, T., Wang, K., Zhang, J., Liu, Y., Gu, Y. G., & Miao, J. (2026). β-Elemene Inhibits K-RAS Mutant Non-Small Cell Lung Cancer Progression and Is Associated with Ferroptosis- and Autophagy-Related Changes. Acta Poloniae Pharmaceutica - Drug Research, 84(1), 119-128. https://doi.org/10.32383/appdr/222556

Vancouver

Cao Y, Zhu J, Chen J, Bian T, Wang K, Zhang J, et al. β-Elemene Inhibits K-RAS Mutant Non-Small Cell Lung Cancer Progression and Is Associated with Ferroptosis- and Autophagy-Related Changes. Acta Poloniae Pharmaceutica - Drug Research. 2026;84(1):119-128. doi:10.32383/appdr/222556

BibTeX
@article{Cao2026,
  author = {Cao, Yue and Zhu, Jun and Chen, Jianle and Bian, Tingting and Wang, Kunxin and Zhang, Jianguo and Liu, Yifei and Gu, Yilu Gu and Miao, Jiefei},
  title = {β-Elemene Inhibits K-RAS Mutant Non-Small Cell Lung Cancer Progression and Is Associated with Ferroptosis- and Autophagy-Related Changes},
  journal = {Acta Poloniae Pharmaceutica - Drug Research},
  year = {2026},
  volume = {84},
  number = {1},
  pages = {119--128},
  doi = {10.32383/appdr/222556}
}
Kostenlos starten →